Correlation of glycated hemoglobin with coagulation profile and hematological parameters in type II diabetes mellitus
HbA1c, hemato-coagulation parameters, in type II DM
DOI:
https://doi.org/10.22122/cdj.v11i1.702Keywords:
Glycosylated Hemoglobin, Coagulation, diabetes mellitusAbstract
BACKGROUND: Patients with diabetes mellitus (DM) have a high risk of atherothrombotic events, with 80% of patients with DM dying a thrombotic death and 75% of these deaths being due to cardiovascular complications. This study aims to evaluate glycated hemoglobin [hemoglobin A1c (HbA1c)] with other parameters [prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and complete blood count (CBC) indices] and compare various hematological parameters between people with DM and people without complications.
METHODS: This cross-sectional study was conducted at Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharashtra, India, over period of 2016 to 2018 on those diagnosed as a case of type II DM (T2DM) with or without complication. Blood samples from all 108 cases were collected. Statistical analysis was performed by Student’s unpaired t-test, Bonferroni multiple comparison test, one-way analysis of variance (ANOVA) test, and chi-square test.
RESULTS: In T2DM cases, mean PT was 12.25 ± 1.22 seconds and APTT in total T2DM cases was 30.12 ± 3.05 seconds (P ≤ 0.005). Hemoglobin (Hb) and hematological parameters like mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) were decreased significantly in DM cases compared to the control group, while red cell distribution width (RDW) and total white blood cell (WBC) counts were found to be significantly increased in DM group (P = 0.021, t = 3.37; P = 0.001, t = 3.51, respectively). The correlation of HbA1c with PT, APTT, international normalized ratio (INR), and fibrinogen was statistically significant (P = 0.005, P = 0.0001, P = 0.005, and P = 0.0001, respectively). The mean fibrinogen level was 422.22 ± 119.77 mg/dl and was statistically significant (P = 0.0001).
CONCLUSION: There was a shortening of PT and APTT, indicating a hypercoagulable state in T2DM. Glycemic control affects the PT, APTT, INR, and fibrinogen levels.
References
Yau M, Maclaren NK, Sperling MA. Etiology and pathogenesis of diabetes mellitus in children and adolescents. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000
Singh RP, Khobragade M, Kumar A. A cross-sectional study on knowledge, attitude and practices among diabetic patients about diabetes and its complications in central Delhi. MRIMS Journal of Health Sciences. 2013; 1(2): 44-7.
Madan R, Gupt B, Saluja S, Kansra UC, Tripathi BK, Guliani BP. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India. 2010; 58: 481-4.
Stratmann B, Tschoepe D. Atherogenesis and atherothrombosis--focus on diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2009; 23(3): 291-303.
Grant PJ. Inflammatory, atherothrombotic aspects of type 2 diabetes. Curr Med Res Opin. 2005; 21(Suppl 1): S5-12.
Soares AL, Sousa M de O, Fernandes APSM, Carvalho M das G. Hemostatic changes in patients with type 2 diabetes mellitus. Rev Bras Hematol Hemoter . 2010; 32(6): 482-8.
Pomero F, Di Minno MN, Fenoglio L, Gianni M, Ageno W, Dentali F. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol. 2015; 52(6): 1007-16.
Agarwal C, Bansal K, Pujani M, Singh K, Chauhan V, Rana D, et al. Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus - a study at a tertiary care center in Delhi. Hematol Transfus Cell Ther. 2019; 41(1): 31-6.
Ambelu YA, Shiferaw MB, Abebe M, Enawgaw B. Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study. J Diabetes Metab Disord. 2018; 17(2): 117-21.
Ephraim RK, Awuku YA, Adu P, Ampomah LT, Adoba P, Panford S, et al. High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana. Ghana Med J. 2017; 51(3): 101-7.
Pan L, Ye Y, Wo M, Bao D, Zhu F, Cheng M, et al. Clinical significance of hemostatic parameters in the prediction for type 2 diabetes mellitus and diabetic nephropathy. Dis Markers. 2018; 2018: 5214376.
Bhutto AR, Abbasi A, Abro AH. Correlation of hemoglobin A1c with red cell width distribution and other parameters of red blood cells in type ii diabetes mellitus. Cureus. 2019; 11(8): e5533.
Buch A, Kaur S, Nair R, Jain A. Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J Lab Physicians. 2017; 9(2): 84-8.
Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications. 2001; 15(1): 44-54.
Dhule S, Gawali S. Platelet aggregation and clotting time in type 2 diabetic males. Natl J Physiol Pharm Pharmacol. 2014; 4(2): 121-123.
Karim F, Akhter Q, Jahan S, Khanom A, Haque S, Yeasmin T, et al. Coagulation impairment in type 2 diabetes mellitus. J Bangladesh Soc Physiol. 2015; 10(1): 26-9.
Zhao Y, Zhang J, Zhang J, Wu J. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS One. 2011; 6(1): e16470.
Chavan PS, Afroz S, Jadhav S. A comparative study of coagulation tests in type 2 diabetes mellitus individuals and health individuals. Int J Med Sci. 2014; 3(1): 290-8.
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362(9): 800-11.
Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, et al. Epidemiological association between fasting plasma glucose and shortened APTT. Clin Biochem. 2009; 42(1-2): 118-20.
Ghongade PV, Atram MA, Shivkumar VB. A study of correlation of plasma fibrinogen levels with glycemic status in type 2 Diabetes Mellitus patients. Journal of Pathology of Nepal. 2020; 10(2): 1746-50.
Yaman H, Celik T, Akgul EO, Cayci T, Kurt Y. Red cell distribution width and acute coronary syndromes. Int J Cardiol. 2010; 145(2): 353.
Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2015; 8: 525-33.
Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications. 2004; 18(3): 173-6.
Alhadas KR, Santos SN, Freitas MMS, Viana SMSA, Ribeiro LC, Costa MB. Are platelet indices useful in the evaluation of type 2 diabetic patients? J Bras Patol Med Lab. 2016; 25(2): 96-102.
Mwambungu A, Kaile T, Korolova L, Kwenda J, Marimo C. Risk factors associated with hypercoagulability in type 2 diabetes mellitus patients at Ndola Central Hospital Zambia. Medical Journal of Zambia. 2014; 41(2): 70-80.
Ismail NEB, Gassoum A, Abdalla MA. Estimation of some hemostatic parameters in diabetes mellitus type 2 among Sudanese patients. Int J Curr Res. 2015; 7(10): 21725-9.
Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004; 27(1): 216-22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
